CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2020 / 12:00PM GMT
Release Date Price: R$30.36 (-0.66%)
Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

Good morning. Welcome to Morgan Stanley's Global Healthcare Conference day 2, and thank you for joining us today. I'm Ricky Goldwasser, Morgan Stanley's healthcare services analyst. And before we get started today, please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press, and if you are a member of the press, please disconnect and reach out separately. And for important disclosures, please see the Morgan Stanley research is closer website at www.morganstanley.com. If you have any questions, please reach out to the Morgan Stanley's sales representative.

And with that out of the way, I'm very pleased to have CVS CEO, Larry Merlo; and CFO, Eva Boratto, here with us today. I mean, Larry, Eva, good morning, and welcome to our conference. 2020 has been obviously a roller coaster year as you've worked in the COVID impact and have played such a critical role in testing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot